According to the latest report by IMARC Group, titled "Lateral Flow Assay Market Report by Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Product (Kits and Reagents, Lateral Flow Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety and Environment Testing, Drug Development and Quality Testing), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care, Pharmaceutical and Biotechnology Companies, and Others), and Region 2025-2033," the global lateral flow assay market size reached USD 10.8 Billion in 2024. Lateral flow assay (LFA) is a diagnostic test that is commonly used for rapid and point-of-care testing. It is a simple and easy-to-use method that detects the presence or absence of a target analyte, such as a virus or bacteria, in a sample. It works by using a paper-based strip, which is coated with specific biomolecules, including antibodies or antigens that can capture the target analyte. It has several advantages over traditional diagnostic tests, such as it is fast, providing rapid diagnostic results, and requiring no special equipment or expertise to perform. It is also relatively inexpensive and can be utilized in remote or resource-limited settings. As a result, it has been used for a wide range of applications, including the detection of infectious diseases, pregnancy testing, and drug testing.
Global Lateral Flow Assay Market Trends:
The global market is primarily driven by the increasing prevalence of infectious diseases among the masses. Coupled with the growing need for rapid and reliable diagnostic tests for quickly discovering and treating diseases, this is providing a boost to the market. Along with this, the rising preference for point-of-care testing in order to improve patient outcomes by providing rapid and precise test results, allowing for earlier diagnosis and care of diseases, is creating a positive market outlook. Moreover, continual technological advancements and the emergence of multiplex LFAs that are capable of detecting multiple target analytes in a single test, using a single sample, which is gaining widespread prominence among the masses. Apart from this, the augmenting adoption of gold nanosphere-based surface-enhanced Raman scattering (SERS) labels in LFA measurements due to strong anti-interference and high sensitivity ability is impacting the market favorably. Other factors, including rapid urbanization, continual improvements in the healthcare sector and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market. On account of the aforementioned factors, the market is anticipated to reach a value of USD 15.7 Billion by 2033, exhibiting a CAGR of 4.2% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Technique, Product, Application, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, Becton Dickinson and Company, Biomérieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Merck KGAA, Perkinelmer Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800